Latest From Cerora Inc.
US Patient Monitoring Devices Market Forecast To Grow $500 Million By 2019 Despite Pricing Pressures, Spending Slowdown
Despite slowdowns in capital equipment spending and strong pricing pressures, the US patient monitoring device market will grow by over $500 million between 2014 and 2019, reaching more than $2.5 billion by 2019 – a CAGR of almost 5%. Several factors are driving growth in this market, including the need for seamless solutions that can provide monitoring from hospital to home, and the growing adoption of portable and wearable technologies.
This Month's Profile Group: Heightened Concussion Awareness Calls For New Detection Tools, features profiles of Cerora, MC10, Oculogica, and Sway Medical. Plus these Start-Ups Across Health Care: Bicycle Therapeutics, Crosstrees Medical, Rescue Therapeutics, and Sensulin.
Cerora Inc. has developed a concussion assessment platform that will collect and analyze many different types of inputs: EEG data, eye gaze measurements, and measures of cognition and voice analysis, to detect concussions. By doing so, the company thinks it will be able to provide a more comprehensive picture of brain injury than competitors whose technologies assess a single factor.
Medical device start-ups are surging into new territory in mild traumatic brain injury or concussion detection, which has heretofore lacked objective diagnostics and monitoring tools. Profiles of Cerora, MC10, Oculogica, and Sway Medical.
In Vitro Diagnostics
- Therapeutic Areas
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- Cerora Inc.
- Senior Management
Adam J Simon, PhD, Pres. & CEO
David M Devilbiss, PhD, Head, R&D
James T Sullivan, Head, Customer Dev.
- Contact Info
Phone: (610) 849-5027
116 Research Dr.
Bethlehem, PA 18015-4731
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.